Maria Lia Palomba
Affiliation: Memorial Sloan-Kettering Cancer Center
- CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphomaMaria Lia Palomba
Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 11:370-9. 2005..These results show that active immunization with xenogeneic DNA vaccines can induce CD8+ T cell-dependent immunity against CD20...
- Active immunotherapy: current state of the art in vaccine approaches for NHLM Lia Palomba
Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Curr Oncol Rep 14:433-40. 2012..What follows is a brief summary of the historical highlights in lymphoma immunotherapy as well as an update on the most recently published clinical trials and a look at future developments...
- CD20 DNA VACCINATION FOR B-CELL LYMPHOMAMaria Palomba; Fiscal Year: 2007..Furthermore, she proposes to explore the effect of CD20 immunization in the post-bone marrow transplant settings. Finally, the candidate proposes to carry out a phase I clinical trial of CD20 DNA vaccine in patients with lymphoma. ..